| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ImmunoGen, Inc. | Director | Common Stock | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Deferred Share Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Restricted Stock Unit | 0 | $0 | $29.30 | 12 Feb 2024 | Direct |
| ImmunoGen, Inc. | Director | Stock Option (Right to Buy) | 0 | $5.19 | 12 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465924014714-wallace-richard-john-2024-02-12 | ImmunoGen, Inc. | 12 Feb 2024 | 13 | $0 | 4 | Director | 12 Feb 2024, 16:45 |
| /report/000141588923014915-wallace-richard-john-2023-11-07 | ImmunoGen, Inc. | 07 Nov 2023 | 2 | +$147,000 | 4 | Director | 08 Nov 2023, 17:53 |
| /report/000141588923009946-wallace-richard-john-2023-06-14 | ImmunoGen, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:43 |
| /report/000141588922006715-wallace-richard-john-2022-06-15 | ImmunoGen, Inc. | 15 Jun 2022 | 2 | +$148,280 | 4 | Director | 17 Jun 2022, 16:12 |
| /report/000117911021006816-wallace-richard-john-2021-06-16 | ImmunoGen, Inc. | 16 Jun 2021 | 2 | +$297,880 | 4 | Director | 17 Jun 2021, 16:22 |